Global Insulin Pump Market is expected to cross US$ 8 Billion by 2024
For More Information: http://www.renub.com/global-insulin-pump-market-is-expected-to-cross-us-8-billion-by-2024-59-nd.php By the year 2024, global insulin pump market is expected to cross US$ 8 Billion. For decades, a surrogate for incursive insulin needles — tablets or insulin delivered via inhalable pumps is seen as a Holy Grail but scientific attempt has so far achieved inadequate success. Although, there is good news for a lot of diabetes patients by the introduction of “Insulin Pump”. Request a free sample copy of the report: http://www.renub.com/contactus.php The paradigm transfer of patients from hospitals to health centers is one of the main factors aiding in the expansion of this market. Earlier, the treatment for diabetes was trendy in hospitals where a dietician or an endocrinologist would lead patients in type-1 diabetes administration. Though, due to the high consultation fees and limited visiting, the patients started looking for other options. In recent times, some health centers have focused only on type-1 and type-2 diabetes administration because of that the concept of exclusive specialty Health centers. Accordingly, the waiting time of patients has essentially diminished and the accessibility of medication and conveyance system at the appended drug store stores has expanded. Likewise, these centers give extra advantages like medical coverage cards, which enable patients to benefit rebates on bills and acquire insulin delivery devices at a generally low cost. Insulin Pump Growth Drivers & Challenges Renub research predicts that the worldwide insulin pump market has increased with a vital growth rate over the years and is anticipated to rise further during the forecast period (2017-2024). The global insulin pump market growth drivers such as ageing population, rise in diabetic population and evolution of new products. Though, the market faces certain hurdles like a threat from the implantable insulin pump, the high cost of insulin pumps, complicated software used in insulin pumps and invention of artificial pancreas etc. Access full Research: http://www.renub.com/insulin-pump-market-and-forecast-worldwide-analysis-127-p.php Companies Insulin Pump Training Models Companies like Insulet, Medtronic, Tandem and Animas make prior Training Models for how to use insulin pump devices. In addition, Diabetes Professionals, healthcare providers, and certified trainers also facilitate new patients.
For More Information: http://www.renub.com/global-insulin-pump-market-is-expected-to-cross-us-8-billion-by-2024-59-nd.php
By the year 2024, global insulin pump market is expected to cross US$ 8 Billion. For decades, a surrogate for incursive insulin needles — tablets or insulin delivered via inhalable pumps is seen as a Holy Grail but scientific attempt has so far achieved inadequate success. Although, there is good news for a lot of diabetes patients by the introduction of “Insulin Pump”.
Request a free sample copy of the report: http://www.renub.com/contactus.php
The paradigm transfer of patients from hospitals to health centers is one of the main factors aiding in the expansion of this market. Earlier, the treatment for diabetes was trendy in hospitals where a dietician or an endocrinologist would lead patients in type-1 diabetes administration. Though, due to the high consultation fees and limited visiting, the patients started looking for other options. In recent times, some health centers have focused only on type-1 and type-2 diabetes administration because of that the concept of exclusive specialty Health centers.
Accordingly, the waiting time of patients has essentially diminished and the accessibility of medication and conveyance system at the appended drug store stores has expanded. Likewise, these centers give extra advantages like medical coverage cards, which enable patients to benefit rebates on bills and acquire insulin delivery devices at a generally low cost.
Insulin Pump Growth Drivers & Challenges
Renub research predicts that the worldwide insulin pump market has increased with a vital growth rate over the years and is anticipated to rise further during the forecast period (2017-2024). The global insulin pump market growth drivers such as ageing population, rise in diabetic population and evolution of new products. Though, the market faces certain hurdles like a threat from the implantable insulin pump, the high cost of insulin pumps, complicated software used in insulin pumps and invention of artificial pancreas etc.
Access full Research: http://www.renub.com/insulin-pump-market-and-forecast-worldwide-analysis-127-p.php
Companies Insulin Pump Training Models
Companies like Insulet, Medtronic, Tandem and Animas make prior Training Models for how to use insulin pump devices. In addition, Diabetes Professionals, healthcare providers, and certified trainers also facilitate new patients.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> <strong>is</strong> <strong>expected</strong> <strong>to</strong> <strong>cross</strong> <strong>US$</strong> 8 <strong>Billion</strong> <strong>by</strong> <strong>2024</strong><br />
Analyst View:<br />
<strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> Forecast<br />
<strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> <strong>is</strong> <strong>expected</strong> <strong>to</strong> <strong>cross</strong> <strong>US$</strong> 8 <strong>Billion</strong> <strong>by</strong> <strong>2024</strong><br />
For More Information:<br />
billion-<strong>by</strong>-<strong>2024</strong>-59-nd.php<br />
Access Full Research:<br />
http://www.renub.com/global-insulin-pump-market-<strong>is</strong>-<strong>expected</strong>-<strong>to</strong>-<strong>cross</strong>-us-8-<br />
http://www.renub.com/insulin-pump-market-and-forecast-worldwide-analys<strong>is</strong>-127-<br />
p.php<br />
Get 10% Free Cus<strong>to</strong>mization in th<strong>is</strong> Report<br />
By the year <strong>2024</strong>, global insulin pump market <strong>is</strong> <strong>expected</strong> <strong>to</strong> <strong>cross</strong> <strong>US$</strong> 8 <strong>Billion</strong>. For decades, a<br />
surrogate for incursive insulin needles — tablets or insulin delivered via inhalable pumps <strong>is</strong> seen<br />
as a Holy Grail but scientific attempt has so far achieved inadequate success. Although, there <strong>is</strong><br />
good news for a lot of diabetes patients <strong>by</strong> the introduction of “<strong>Insulin</strong> <strong>Pump</strong>”.<br />
Request a free sample copy of the report: http://www.renub.com/contactus.php<br />
The paradigm transfer of patients from hospitals <strong>to</strong> health centers <strong>is</strong> one of the main fac<strong>to</strong>rs<br />
aiding in the expansion of th<strong>is</strong> market. Earlier, the treatment for diabetes was trendy in<br />
hospitals where a dietician or an endocrinolog<strong>is</strong>t would lead patients in type-1 diabetes<br />
admin<strong>is</strong>tration. Though, due <strong>to</strong> the high consultation fees and limited v<strong>is</strong>iting, the patients<br />
started looking for other options.<br />
© Renub Research LLP Page 1 of 4
<strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> <strong>is</strong> <strong>expected</strong> <strong>to</strong> <strong>cross</strong> <strong>US$</strong> 8 <strong>Billion</strong> <strong>by</strong> <strong>2024</strong><br />
In recent times, some health centers have focused only on type-1 and type-2 diabetes<br />
admin<strong>is</strong>tration because of that the concept of exclusive specialty Health centers.<br />
Accordingly, the waiting time of patients has essentially dimin<strong>is</strong>hed and the accessibility of<br />
medication and conveyance system at the appended drug s<strong>to</strong>re s<strong>to</strong>res has expanded. Likew<strong>is</strong>e,<br />
these centers give extra advantages like medical coverage cards, which enable patients <strong>to</strong><br />
benefit rebates on bills and acquire insulin delivery devices at a generally low cost.<br />
<strong>Insulin</strong> <strong>Pump</strong> Growth Drivers & Challenges<br />
Renub research predicts that the worldwide insulin pump market has increased with a vital<br />
growth rate over the years and <strong>is</strong> anticipated <strong>to</strong> r<strong>is</strong>e further during the forecast period (2017-<br />
<strong>2024</strong>). The global insulin pump market growth drivers such as ageing population, r<strong>is</strong>e in diabetic<br />
population and evolution of new products. Though, the market faces certain hurdles like a<br />
threat from the implantable insulin pump, the high cost of insulin pumps, complicated software<br />
used in insulin pumps and invention of artificial pancreas etc.<br />
Access full Research: http://www.renub.com/insulin-pump-market-and-forecastworldwide-analys<strong>is</strong>-127-p.php<br />
Companies <strong>Insulin</strong> <strong>Pump</strong> Training Models<br />
Companies like Insulet, Medtronic, Tandem and Animas make prior Training Models for how <strong>to</strong><br />
use insulin pump devices. In addition, Diabetes Professionals, healthcare providers, and<br />
certified trainers also facilitate new patients.<br />
North America leads <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> among Rest of the World<br />
Geographically, North America <strong>is</strong> the biggest market for the insulin pump globally and<br />
adornments showcase, with the U.S. contribute a noteworthy offer, trailed <strong>by</strong> Europe. North<br />
America and Europe will keep on dominating the market till <strong>2024</strong>. Nonetheless, a magnificent<br />
share of the development in the insulin pump and frill showcase <strong>is</strong> required in the developing<br />
markets like Asia-Pacific that <strong>is</strong> attributable <strong>to</strong> the developing number of diabetes patients and<br />
expanding mindfulness <strong>to</strong>wards glycemic control and propel insulin conveyance gadgets in these<br />
areas.<br />
Enhanced Reimbursement Policy <strong>by</strong> Public & Private Insurers Helped Patients In<br />
Developed Nations<br />
The better execution of public & private reimbursement policy about the insulin pump<br />
makes United States insulin pump market largest worldwide. In spite of all these people in the<br />
United States are aware of insulin pump and how it’s been used <strong>to</strong> manage severe diabetes<br />
complication either occurred <strong>by</strong> type 1 diabetes or type 2 diabetes. Conventional pumps<br />
represent such an extensive segment of the market since they are a significantly more settled<br />
market, in respect <strong>to</strong> the fix pump showcase which was just propelled in Europe over the most<br />
recent five years. Germany records the highest number of insulin pump user due <strong>to</strong> its overall<br />
population and relatively number of type 1 diabetes patients in Europe.<br />
© Renub Research LLP Page 2 of 4
<strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> <strong>is</strong> <strong>expected</strong> <strong>to</strong> <strong>cross</strong> <strong>US$</strong> 8 <strong>Billion</strong> <strong>by</strong> <strong>2024</strong><br />
Table of Contents:<br />
1. Executive Summary<br />
2. <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> Users & Forecast<br />
3. <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> & Forecast<br />
4. <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> Share & Forecast<br />
5. Training Model for Patients & HCP – of Medtronic, Animas, Insulet Corp &<br />
Tandem Diabetes Care<br />
6. Differentiation Points of <strong>Insulin</strong> <strong>Pump</strong> Products Available Worldwide<br />
7. United States Diabetes Population (2010 – <strong>2024</strong>)<br />
8. United States <strong>Insulin</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
9. Canada Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
10. Canada <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
11. Germany Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
12. Germany <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
13. Australia Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
14. Australia <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
15. France Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
16. France <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
17. Netherlands Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
18. Netherlands <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
19. Switzerland Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
© Renub Research LLP Page 3 of 4
<strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong> <strong>is</strong> <strong>expected</strong> <strong>to</strong> <strong>cross</strong> <strong>US$</strong> 8 <strong>Billion</strong> <strong>by</strong> <strong>2024</strong><br />
20. Switzerland <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
21. Sweden Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
22. Sweden <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
23. Israel Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
24. Israel <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
25. United Kingdom Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
26. United Kingdom <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
27. Japan Diabetes Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
28. Japan <strong>Insulin</strong> <strong>Pump</strong> Analys<strong>is</strong> (2010 – <strong>2024</strong>)<br />
29. Key Companies Analys<strong>is</strong> for <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong><br />
30. Companies <strong>Insulin</strong> <strong>Pump</strong> Clinical Trials<br />
31. Growth Drivers for <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong><br />
32. Challenges for <strong>Global</strong> <strong>Insulin</strong> <strong>Pump</strong> <strong>Market</strong><br />
33. Appendix<br />
Medical Devices <strong>Market</strong> Report:<br />
http://www.renub.com/medical-devices-15-c.php<br />
Renub Research - North America<br />
Rajat Gupta<br />
225 Kr<strong>is</strong>tie Ln, Roswell<br />
Georgia 30076, United States<br />
Renub Research - Asia<br />
Ankit M<strong>is</strong>hra<br />
C – 86, Sec<strong>to</strong>r – 10<br />
Noida 201301, India<br />
Tel: +1-678-302-0700<br />
Email: info@renub.com<br />
www.renub.com<br />
Tel: +91-120-421-9822<br />
Email: info@renub.com<br />
www.renub.com<br />
© Renub Research LLP Page 4 of 4
Change language